| [1] | Shubhra Q. T. H. (2024). Multi-compartment liposomes forge new paths in drug delivery. Nat. Chem. 16:1578−1579. DOI:10.1038/s41557-024-01638-2 |
| [2] | Pilkington C. P., Gispert I., Chui S. Y., et al. (2024). Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release. Nat. Chem. 16:1612−1620. DOI:10.1038/s41557-024-01584-z |
| [3] | Witten J., Raji I., Manan R. S., et al. (2024). Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nat. Biotechnol. DOI:10.1038/s41587-024-02490-y. |
| [4] | He S., Gui J., Xiong K., et al. (2022). A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases. J. Nanobiotechnol. 20:101. DOI:10.1186/s12951-022-01307-x |
| [5] | Xu Y., Liu X., Cao X., et al. (2021). Artificial intelligence: A powerful paradigm for scientific research. The Innovation 2:100179. DOI:10.1016/j.xinn.2021.100179 |
| Cai X. and Shubhra Q. (2025). AI-designed lipid nanoparticles forge a path for pulmonary gene therapy. The Innovation Materials 3:100123. https://doi.org/10.59717/j.xinn-mater.2024.100123 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
AI-driven lipid nanoparticle optimization for pulmonary mRNA delivery.